Evidence map›Paper›PMID 27907118›Full record

ArticlePloS one2016

End-to-Side Neurorrhaphy as Schwann Cells Provider to Acellular Nerve Allograft and Its Suitable Application.

Hidekazu Yoshizawa, Daiki Senda, Yuhei Natori, Rica Tanaka, Hiroshi Mizuno, Ayato Hayashi

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hidekazu YoshizawaDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Daiki SendaDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Yuhei NatoriDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Rica TanakaDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Hiroshi MizunoDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.
Ayato HayashiDepartment of Plastic and Reconstructive Surgery, Juntendo University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Axonal regeneration relies on support from proliferating host Schwann cells (SCs), and previous studies on acellular nerve allografts (ANGs) suggest that axons can regenerate into ANGs within a limited distance. Numerous studies have demonstrated that the supplementation of ANGs with exogenous factors, such as cultured SCs, stem cells, and growth factors, promote nerve regeneration in ANGs. However, there are several problems associated with their utilization. In this study, we investigated whether end-to-side (ETS) neurorrhaphy, which is an axonal provider, could be useful as an SC provider to support axonal elongation in ANGs. We found that ETS neurorrhaphy effectively promoted SC migration into ANGs when an epineurium window combined with partial neurectomy was performed, and the effectiveness increased when it was applied bilaterally. When we transplanted ANGs containing migrated SCs via ETS neurorrhaphy (hybrid ANGs) to the nerve gap, hybrid ANGs increased the number of regenerated axons and facilitated rapid axonal elongation, particularly when ETS neurorrhaphy was applied to both edges of the graft. This approach may represent a novel application of ETS neurorrhaphy and lead to the development of hybrid ANGs, making ANGs more practical in a clinical setting.

Indexed as

AllograftsNerve RegenerationNerve TransferAnimalsAxonsCell MovementCell TrackingMiceMice, TransgenicMicroscopy, ConfocalModels, AnimalMuscle, SkeletalNeuromuscular JunctionSchwann Cells

Identifiers

PMID27907118
PMCPMC5132318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.